Error: Could not add to watchlist. X

Regulus Therapeutics Inc

+ Watchlist
RGLS:US
NASDAQ GM
8.26
USD
0.07
0.84%
As of 20:10:00 ET on 09/01/2015.
Open
8.00
Day Range
7.98 - 8.55
Volume
778,899
Previous Close
8.33
52Wk Range
6.23 - 25.60
1 Yr Return
17.33%
Open
8.00
Day Range
7.98 - 8.55
Volume
778,899
Previous Close
8.33
52Wk Range
6.23 - 25.60
1 Yr Return
17.33%
YTD Return
-48.50%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.23
Market Cap (m USD)
428.855
Shares Outstanding (m)
51.920
Price/Sales (TTM)
30.15
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulas's research consists of scientists from across the world.
ADDRESS
1896 Rutherford Road
Carlsbad, CA 92008-7208
United States
PHONE
1-800-734-8587
  • Paul C Grint
    President/CEO
  • David Szekeres
    CFO/CAO/General Counsel
  • Amy Conrad
    Senior Dir:Investor Relations
Show More